Literature DB >> 17576892

Reduction of interleukin 8 gene expression in reflux esophagitis and Barrett's esophagus with antireflux surgery.

Daniel S Oh1, Steven R DeMeester, Daniel Vallbohmer, Ryutaro Mori, Hidekazu Kuramochi, Jeffrey A Hagen, John Lipham, Kathleen D Danenberg, Peter V Danenberg, Parakrama Chandrasoma, Tom R DeMeester.   

Abstract

HYPOTHESIS: Chronic inflammation of esophageal mucosa secondary to refluxed gastric juice increases gene expression of interleukin 8 (IL-8). Antireflux surgery can reduce this overexpression.
DESIGN: Prospective analysis of archival paraffin-embedded tissue.
SETTING: Academic tertiary medical center. PATIENTS AND METHODS: One hundred eight patients with reflux symptoms were classified according to pH monitoring and endoscopic and histologic findings. Twenty patients did not have reflux or mucosal injury; 47 had reflux disease (16 esophagitis and 31 Barrett's esophagus), 20 had dysplasia, and 21 had adenocarcinoma. Microdissection was performed to exclude inflammatory cells and stromal tissue. After RNA isolation and reverse transcription, IL-8 messenger RNA expression was measured using quantitative real-time polymerase chain reaction. All patients with reflux disease had Nissen fundoplication with biopsies at matched levels within the esophagus preoperation and postoperation.
RESULTS: Expression of IL-8 was increased in patients with reflux compared with those without reflux. Patients with the highest IL-8 expression were those with Barrett's dysplasia and adenocarcinoma (P<.001). In patients with reflux, Nissen fundoplication led to significantly decreased IL-8 expression compared with preoperative levels in esophagitis (P = .01) and Barrett's esophagus (P = .03).
CONCLUSIONS: Interleukin 8 messenger RNA expression increases during the progression of reflux disease from normal squamous mucosa to esophageal adenocarcinoma. Elimination of reflux with Nissen fundoplication significantly reduces IL-8 expression in both squamous and Barrett's mucosa. These results demonstrate that effective antireflux surgery can modulate the gene expression of esophageal mucosa and may impact the natural history of reflux disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17576892     DOI: 10.1001/archsurg.142.6.554

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  22 in total

Review 1.  Gastroesophageal reflux disease--from reflux episodes to mucosal inflammation.

Authors:  Arne Kandulski; Peter Malfertheiner
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-11-22       Impact factor: 46.802

Review 2.  Chemokines, chemokine receptors and the gastrointestinal system.

Authors:  Hiroshi Miyazaki; Kazuaki Takabe; W Andrew Yeudall
Journal:  World J Gastroenterol       Date:  2013-05-21       Impact factor: 5.742

3.  Reflux, Barrett's, and adenocarcinoma of the esophagus: can we disrupt the pathway?

Authors:  Steven R DeMeester
Journal:  J Gastrointest Surg       Date:  2010-01-22       Impact factor: 3.452

Review 4.  Inflammatory mediators in gastroesophageal reflux disease: impact on esophageal motility, fibrosis, and carcinogenesis.

Authors:  Florian Rieder; Piero Biancani; Karen Harnett; Lisa Yerian; Gary W Falk
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-03-18       Impact factor: 4.052

Review 5.  Microbiome, innate immunity, and esophageal adenocarcinoma.

Authors:  Jonathan Baghdadi; Noami Chaudhary; Zhiheng Pei; Liying Yang
Journal:  Clin Lab Med       Date:  2014-09-26       Impact factor: 1.935

6.  Laparoscopic Nissen Fundoplication Plus Mid-gastric Plication for Treatment of Obese Patients with Gastroesophageal Reflux Disease.

Authors:  Ahmed Talha; Mohammed Ibrahim
Journal:  Obes Surg       Date:  2018-02       Impact factor: 4.129

7.  In oesophageal squamous cells exposed to acidic bile salt medium, omeprazole inhibits IL-8 expression through effects on nuclear factor-κB and activator protein-1.

Authors:  Xiaofang Huo; Xi Zhang; Chunhua Yu; Qiuyang Zhang; Edaire Cheng; David H Wang; Thai H Pham; Stuart J Spechler; Rhonda F Souza
Journal:  Gut       Date:  2013-09-18       Impact factor: 23.059

8.  The columnar-lined mucosa at the gastroesophageal junction in non-human primates.

Authors:  Carlos A Rubio; Edward J Dick; Natalia E Schlabritz-Loutsevitch; Abiel Orrego; Gene B Hubbard
Journal:  Int J Clin Exp Pathol       Date:  2008-01-20

Review 9.  Antireflux surgery for dysplastic Barrett.

Authors:  Marco E Allaix; Marco G Patti
Journal:  World J Surg       Date:  2015-03       Impact factor: 3.352

10.  Acid burn or cytokine sizzle in the pathogenesis of heartburn?

Authors:  Xiaofang Huo; Rhonda F Souza
Journal:  J Gastroenterol Hepatol       Date:  2013-03       Impact factor: 4.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.